BHG - Bright Health Group, Inc. Stock Price, Fair Value and News

18.44USD-0.21 (-1.13%)Delayed as of 17 May 2024, 12:58 pm ET

Market Summary

USD18.44-0.21

Delayedas of 17 May 2024, 12:58 pm

-1.13%

BHG Stock Price

View Fullscreen

BHG RSI Chart

BHG Valuation

Market Cap

153.4M

Price/Earnings (Trailing)

-0.14

Price/Sales (Trailing)

0.14

EV/EBITDA

0.06

Price/Free Cashflow

-0.07

BHG Price/Sales (Trailing)

BHG Profitability

EBT Margin

-49.73%

Return on Equity

84.3%

Return on Assets

-96.21%

Free Cashflow Yield

-1.4K%

BHG Fundamentals

BHG Revenue

Revenue (TTM)

1.1B

Rev. Growth (Yr)

-67.59%

Rev. Growth (Qtr)

-16.31%

BHG Earnings

Earnings (TTM)

-1.1B

Earnings Growth (Yr)

83.71%

Earnings Growth (Qtr)

90.1%

Breaking Down BHG Revenue

52 Week Range

18.90

(Low)(High)

Last 7 days

10.3%

Last 30 days

-0.7%

Last 90 days

15.0%

Trailing 12 Months

64.3%

How does BHG drawdown profile look like?

BHG Financial Health

Current Ratio

0.77

Debt/Equity

-0.05

Debt/Cashflow

-32.53

BHG Investor Care

Shares Dilution (1Y)

3.43%

Diluted EPS (TTM)

-130.53

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	1.1B	0	0	0
2023	1.7B	1.8B	1.9B	1.6B
2022	1.9B	1.6B	1.3B	1.5B
2021	764.4M	1.0B	1.3B	1.5B
2020	0	358.7M	436.8M	514.9M
2019	0	0	0	280.7M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Bright Health Group, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Dec 15, 2023	mikan george lawrence iii	sold	-154,740	6.14	-25,202	ceo & president
Dec 14, 2023	mikan george lawrence iii	acquired	-	-	52,500	ceo & president
Oct 05, 2023	matushak jay	sold	-496	5.71	-87.00	chief financial officer
Oct 04, 2023	matushak jay	acquired	-	-	264	chief financial officer
Aug 16, 2023	cook jeffrey s	sold	-13,354	10.84	-1,232	chief operating officer
Aug 15, 2023	cook jeffrey s	acquired	-	-	4,759	chief operating officer
May 13, 2023	adkins kedrick d jr	acquired	-	-	95,109	-
May 13, 2023	slavitt andrew m	acquired	-	-	95,109	-
May 13, 2023	newhall adair	acquired	-	-	95,109	-
May 13, 2023	manders matthew g	acquired	-	-	118,886	-

Which funds bought or sold BHG recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 15, 2024	Steward Partners Investment Advisory, LLC	unchanged	-	-70.00	403	-%
May 15, 2024	NEA Management Company, LLC	unchanged	-	-2,137,980	17,725,000	1.10%
May 15, 2024	Deer Management Co. LLC	sold off	-100	-7,624,030	-	-%
May 15, 2024	Deer Management Co. LLC	new	-	6,494,920	6,494,920	1.18%
May 15, 2024	HarbourVest Partners LLC	unchanged	-	-59,574	342,680	0.16%
May 15, 2024	Royal Bank of Canada	reduced	-20.5	-7,000	17,000	-%
May 15, 2024	Blackstone Inc.	unchanged	-	-51,885	298,454	-%
May 15, 2024	Tower Research Capital LLC (TRC)	new	-	12,155	12,155	-%
May 15, 2024	Greycroft LP	unchanged	-	-156,338	899,288	0.63%
May 15, 2024	BARCLAYS PLC	sold off	-100	-1,000	-	-%

Are Funds Buying or Selling BHG?

Are funds buying BHG calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own BHG

No. of Funds

Unveiling Bright Health Group, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Apr 10, 2024	new enterprise associates 15, l.p.	56.6%	6,955,633	SC 13D/A
Feb 14, 2024	stepstone group lp	6.8%	543,776	SC 13D/A
Feb 14, 2024	deer x & co. ltd.	5.6%	448,648	SC 13G/A
Dec 22, 2023	new enterprise associates 15, l.p.	54.2%	6,213,259	SC 13D/A
Sep 28, 2023	new enterprise associates 15, l.p.	53.1%	5,937,128	SC 13D/A
Aug 21, 2023	new enterprise associates 15, l.p.	50.7%	5,384,865	SC 13D/A
Oct 21, 2022	new enterprise associates 15, l.p.	45.2%	359,305,833	SC 13D/A
Feb 15, 2022	deer x & co. ltd.	5.7%	35,891,982	SC 13G

Recent SEC filings of Bright Health Group, Inc.

View All Filings

Date Filed	Form Type	Document
May 16, 2024	S-8	Employee Benefits Plan
May 14, 2024	4	Insider Trading
May 14, 2024	4	Insider Trading
May 14, 2024	4	Insider Trading
May 14, 2024	4	Insider Trading
May 14, 2024	4	Insider Trading
May 14, 2024	4	Insider Trading
May 14, 2024	4	Insider Trading
May 14, 2024	4	Insider Trading
May 14, 2024	4	Insider Trading

Peers (Alternatives to Bright Health Group, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	479.9B	379.5B	11.20%	7.55%	31.24	1.26	12.96%	-25.81%
CI	96.4B	206.0B	-2.18%	28.90%	25.01	0.47	12.55%	-43.95%
HCA	84.6B	66.7B	2.85%	17.20%	15.46	1.27	9.59%	-4.59%
CVS	72.2B	360.9B	-16.66%	-17.14%	9.86	0.2	9.07%	78.49%
CNC	41.2B	155.5B	6.71%	14.75%	15.05	0.26	6.34%	84.42%
UHS	12.0B	14.7B	10.86%	33.14%	14.73	0.82	7.99%	19.23%
DVA	12.0B	12.3B	5.19%	38.43%	14.68	0.97	5.77%	58.74%
MID-CAP
CHE	8.6B	2.3B	-6.84%	5.15%	30.33	3.75	5.96%	18.29%
ACHC	6.2B	3.0B	-6.14%	-7.19%	-547.09	2.07	10.92%	-104.06%
AMEH	2.3B	1.5B	8.58%	22.04%	36.93	1.59	19.34%	40.15%
AMN	2.2B	3.5B	3.96%	-38.10%	15.61	0.64	-27.67%	-62.43%
SMALL-CAP
ADUS	1.8B	1.1B	13.47%	25.04%	27.49	1.66	11.45%	30.74%
BKD	1.4B	3.0B	11.90%	88.00%	-7.82	0.45	4.98%	4.88%
BEAT	55.6M	-	17.22%	-3.21%	-3.68	-	-	-1.05%
AMS	21.1M	21.6M	17.97%	25.63%	38.19	0.98	9.04%	-50.63%

Bright Health Group, Inc. News

Latest updates

Bright Health Group, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2019Q4
Revenue	-16.3%	245,095,000	292,871,000	269,399,000	297,982,000	756,341,000	569,374,000	193,363,000	149,340,000	613,263,000	380,223,000	464,957,000	415,105,000	252,748,000	302,434,000	352,120,000	296,856,000	-
Operating Expenses	196.4%	268,197,000	90,473,500	732,174,000	321,396,000	842,087,000	77,623,000	289,290,000	220,859,000	773,126,000	-1,588,554,000	1,374,938,000	1,172,885,000	897,391,000	-256,044,000	411,376,000	324,092,000	-
S&GA Expenses	-	-	-	72,532,000	70,280,000	140,324,000	339,514,500	85,566,000	78,997,000	159,117,000	-251,637,000	309,790,000	261,060,000	208,240,000	-35,587,000	97,379,000	88,827,000	-
EBITDA Margin	-23.9%	-0.45	-0.36	-0.33	-0.13	-0.16	-0.22	-0.18	-0.27	-0.23	-0.20	-0.34	-0.20	-	-	-	-	-
Interest Expenses	-73.9%	2,930,000	11,205,000	10,041,000	9,170,000	7,787,000	6,387,000	4,905,000	337,000	1,193,000	948,000	1,594,000	4,142,000	546,000	-	-	-	-
Income Taxes	-55.3%	700,000	1,564,500	-3,385,000	-900,000	1,300,000	-9,236,500	3,401,000	2,900,000	3,200,000	-8,307,500	73,000	-19,500,000	1,200,000	1,000	-	-9,162,000	-
Earnings Before Taxes	115.6%	6,351,000	-40,800,000	-482,690,000	-32,584,000	-93,533,000	-72,955,500	-100,830,000	-71,858,000	-160,272,000	33,584,000	-296,649,000	-63,187,000	-23,379,000	-76,611,000	-59,256,000	-27,236,000	-
EBT Margin	-23.8%	-0.50	-0.40	-0.36	-0.17	-0.20	-0.27	-0.22	-0.31	-0.26	-0.23	-0.36	-0.22	-	-	-	-	-
Net Income	90.1%	-28,518,000	-287,967,000	-633,895,000	-112,832,000	-175,011,000	-680,408,000	-316,840,000	-274,666,000	-195,234,000	-817,309,000	-297,873,000	-44,518,000	-25,162,000	-163,832,000	-59,256,000	-18,074,000	-
Net Income Margin	-28.5%	-0.96	-0.75	-0.85	-0.71	-0.87	-0.96	-1.20	-0.99	-0.72	-0.78	-0.42	-0.29	-	-	-	-	-
Free Cashflow	85.3%	-48,781,000	-331,498,000	-1,671,525,000	-109,533,000	-616,887,000	116,810,000	-621,302,000	232,244,000	479,266,000	-160,787,000	-274,160,000	147,204,000	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet													(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2020Q4
Assets	-9.8%	1,105	1,225	2,056	4,393	4,848	4,665	4,612	5,261	5,275	3,598	3,575	3,600	1,811
Current Assets	-10.5%	974	1,089	1,912	3,851	3,771	3,571	2,638	3,160	3,295	1,660	1,628	2,091	1,180
Cash Equivalents	185.7%	249	87.00	113	108	383	217	1,606	1,428	1,506	1,061	956	1,506	488
Net PPE	-12.8%	13.00	14.00	18.00	18.00	41.00	21.00	48.00	48.00	41.00	38.00	31.00	19.00	12.00
Goodwill	-	-	-	-	401	760	401	761	835	835	831	842	275	45.00
Liabilities	-9.0%	1,347	1,480	1,861	3,664	4,044	3,725	3,284	3,667	3,428	2,325	1,508	1,409	594
Current Liabilities	-9.5%	1,260	1,391	1,831	3,635	4,012	3,693	3,251	3,631	3,389	2,284	1,452	1,364	565
Short Term Borrowings	-100.0%	-	304	354	304	304	304	304	-	-	155	-	-	-
Long Term Debt	0%	66.00	66.00	-	-	-	-	-	-	-	-	-	-	-
Shareholder's Equity	0.2%	-1,261	-1,263	-	-	-339	-200	358	682	957	1,145	1,937	2,150	-
Retained Earnings	-0.4%	-4,323	-4,307	-4,078	-3,444	-3,331	-3,156	-2,476	-2,170	-1,896	-1,700	-886	-585	-515
Additional Paid-In Capital	0.6%	3,075	3,056	3,038	3,021	3,006	2,972	2,940	2,915	2,894	2,861	2,823	2,735	10.00
Shares Outstanding	2.1%	8.00	8.00	8.00	8.00	8.00	8.00	8.00	8.00	8.00	8.00	8.00	2.00	-
Float	-	-	-	-	47.00	-	-	-	549	-	-	-	5,069	-

Cashflow (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Cashflow (Quarterly)																	(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2019Q4
Cashflow From Operations	85.3%	-48.72	-331	-1,671	-109	-615	123	-614	242	485	-151	-264	154	344	-68.58	-75.70	-	-
Share Based Compensation	3.0%	19.00	18.00	17.00	16.00	33.00	32.00	24.00	20.00	33.00	25.00	24.00	14.00	5.00	2.00	2.00	-	-
Cashflow From Investing	868.6%	198	-25.81	988	-529	687	33.00	488	-318	-633	100	-284	-311	-56.27	-160	-76.70	-	-
Cashflow From Financing	-3195.4%	-275	9.00	46.00	-3.15	-1.80	171	304	-1.48	593	156	-1.19	689	200	25.00	476	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

BHG Income Statement

2024-03-31

Condensed Consolidated Statements of Income (Loss) - USD ($)
shares in Thousands

3 Months Ended

Mar. 31, 2024

Mar. 31, 2023

Revenue:

ACO REACH revenue

$ 171,811,000

$ 239,807,000

Investment income

203,000

8,000

Total revenue

245,095,000

300,550,000

Operating expenses:

Medical costs

196,874,000

260,120,000

Operating costs

66,822,000

79,518,000

Bad debt expense

(3,000)

Restructuring charges

(58,000)

301,000

Depreciation and amortization

4,562,000

5,483,000

Total operating expenses

268,197,000

345,422,000

Operating loss

(23,102,000)

(44,872,000)

Interest expense

2,930,000

7,787,000

Warrant income

(2,072,000)

Gain on troubled debt restructuring

(30,311,000)

Income (loss) from continuing operations before income taxes

6,351,000

(52,659,000)

Income tax expense

663,000

1,259,000

Net income (loss) from continuing operations

5,688,000

(53,918,000)

Loss from discontinued operations, net of tax (Note 15)

(9,865,000)

(115,543,000)

Net Loss

(4,177,000)

(169,461,000)

Net income from continuing operations attributable to noncontrolling interests

(11,737,000)

(5,550,000)

Net loss attributable to NeueHealth, Inc. common shareholders

$ (28,518,000)

$ (186,905,000)

Basic and diluted loss per share attributable to NeueHealth, Inc. common shareholders

Continuing operations, basic (in dollars per share)

$ (2.31)

$ (9.04)

Continuing operations, diluted (in dollars per share)

(2.31)

(9.04)

Discontinued operations, basic (in dollars per share)

(1.22)

(14.64)

Discontinued operations, diluted (in dollars per share)

(1.22)

(14.64)

Basic loss per share (in dollars per share)

(3.53)

(23.68)

Diluted loss per share (in dollars per share)

$ (3.53)

$ (23.68)

Basic weighted-average common shares outstanding (in shares)

^[1]

8,079

7,894

Diluted weighted-average common shares outstanding (in shares)

^[1]

8,079

7,894

Series A preferred stock dividend accrued

Operating expenses:

Series A and B preferred stock dividend accrued

$ (10,294,000)

$ (9,714,000)

Series B preferred stock dividend accrued

Operating expenses:

Series A and B preferred stock dividend accrued

(2,310,000)

(2,180,000)

Capitated revenue

Revenue:

Revenue

61,466,000

49,548,000

Service revenue

Revenue:

Revenue

$ 11,615,000

$ 11,187,000

[1]	*Shares have been retroactively adjusted to reflect the decreased number of shares resulting from a 1 for 80 reverse stock split effective May 22, 2023.

BHG Balance Sheet

2024-03-31

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 112,762	$ 87,299
Short-term investments	0	6,265
Accounts receivable, net of allowance of $10,358 and $14,023, respectively	39,938	39,084
ACO REACH performance year receivable	646,627	115,878
Current assets of discontinued operations (Note 15)	149,352	822,570
Prepaids and other current assets	25,786	17,831
Total current assets	974,465	1,088,927
Other assets:
Property, equipment and capitalized software, net	12,650	14,499
Intangible assets, net	90,345	93,238
Other non-current assets	27,668	28,816
Total other assets	130,663	136,553
Total assets	1,105,128	1,225,480
Current liabilities:
Medical costs payable	157,601	157,903
Accounts payable	6,263	11,841
Short-term borrowings	0	303,947
ACO REACH performance year obligation	529,657	0
Current liabilities of discontinued operations (Note 15)	345,048	699,758
Risk share payable to deconsolidated entity	123,981	123,981
Warrant liability	11,899	13,971
Other current liabilities	85,101	79,856
Total current liabilities	1,259,550	1,391,257
Long-term borrowings	66,400	66,400
Other liabilities	21,212	22,441
Total liabilities	1,347,162	1,480,098
Commitments and contingencies (Note 10)
Redeemable noncontrolling interests	98,761	88,908
Redeemable Series A and B preferred stock	920,417	920,417
Shareholders’ equity (deficit):
Common stock, $0.0000 par value; $3,000,000 shares authorized in 2024 and 2023; $8,225 and $8,054 shares issued and outstanding in 2024 and 2023, respectively	1	1
Additional paid-in capital	3,074,654	3,056,027
Accumulated deficit	(4,323,763)	(4,307,849)
Accumulated other comprehensive loss	(104)	(122)
Treasury Stock, at cost, $32 shares at March 31, 2024, and December 31, 2023, respectively	(12,000)	(12,000)
Total shareholders’ equity (deficit)	(1,261,212)	(1,263,943)
Total liabilities, redeemable noncontrolling interests, redeemable preferred stock and shareholders’ equity (deficit)	1,105,128	1,225,480
Redeemable Series A preferred stock
Current liabilities:
Redeemable Series A and B preferred stock	747,481	747,481
Redeemable Series B preferred stock
Current liabilities:
Redeemable Series A and B preferred stock	$ 172,936	$ 172,936

About Bright Health Group, Inc.

Bright Health Group, Inc., a healthcare company, provides health insurance policies in the United States. It operates in two segments, Bright HealthCare and Consumer Care. The Consumer Care segment delivers virtual and in-person clinical care services contracts through primary care clinics. It operates managed and affiliated risk-bearing clinics within its integrated care delivery system, which included embedded pharmacy, laboratory, radiology, and population health focused specialty services. The Bright HealthCare segment offers medicare health plan products to consumers. The company was formerly known as Bright Health Inc. and changed its name to Bright Health Group, Inc. in February 2021. Bright Health Group, Inc. was incorporated in 2015 and is headquartered in Minneapolis, Minnesota.

CEO	Mr. George Lawrence Mikan III
WEBSITE	brighthealthgroup.com
INDUSTRY	Healthcare Plans
EMPLOYEES	2840

Bright Health Group, Inc. Frequently Asked Questions

What is the ticker symbol for Bright Health Group, Inc.? What does BHG stand for in stocks?

BHG is the stock ticker symbol of Bright Health Group, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Bright Health Group, Inc. (BHG)?

As of Thu May 16 2024, market cap of Bright Health Group, Inc. is 153.39 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of BHG stock?

You can check BHG's fair value in chart for subscribers.

What is the fair value of BHG stock?

You can check BHG's fair value in chart for subscribers. The fair value of Bright Health Group, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Bright Health Group, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for BHG so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Bright Health Group, Inc. a good stock to buy?

The fair value guage provides a quick view whether BHG is over valued or under valued. Whether Bright Health Group, Inc. is cheap or expensive depends on the assumptions which impact Bright Health Group, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BHG.

What is Bright Health Group, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu May 16 2024, BHG's PE ratio (Price to Earnings) is -0.14 and Price to Sales (PS) ratio is 0.14. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. BHG PE ratio will change depending on the future growth rate expectations of investors.